Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 23, Number 10—October 2017
Synopsis

Surveillance of Extrapulmonary Nontuberculous Mycobacteria Infections, Oregon, USA, 2007–2012

Emily HenkleComments to Author , Katrina Hedberg, Sean D. Schafer, and Kevin L. Winthrop
Author affiliations: Oregon Public Health Division, Portland, Oregon, USA (E. Henkle, K. Hedberg, S.D. Schafer); Oregon Health and Science University, Portland (E. Henkle, K.L. Winthrop)

Main Article

Table

Characteristics of 334 nontuberculous mycobacterium infections, Oregon, USA, 2007–2012*

Category
Infection site† Total, N = 334
Skin/soft tissue, n = 197
Disseminated, n = 57
Lymph node, n = 28
Joint, n = 14
Other, n = 38
Annual incidence/100,000 population
0.9
0.2
0.1
0.1
0.2
1.5
Patient demographics
Sex
F 115 (58) 19 (33) 15 (54) 7 (50) 20 (52) 176 (53)
M 82 (42) 38 (67) 13 (46) 7 (50) 18 (48) 158 (47)
Median age, y (range) 51 (0.8–92) 41 (1–82) 44 (0.8–76) 70 (39–88) 61 (21–88) 51 (0.8–92)
HIV positive
8 (4)
34 (60)
5 (18)
0 (0)
3 (8)
50 (15)
Mycobacterium species
  Rapid-growing species 85 (43.1) 5 (8.8) 2 (7.1) 3 (21.4) 13 (34.2) 108 (32.3)
    M. chelonae/abscessus complex 40 (20.3) 2 (3.5) 1 (3.6) 1 (7.1) 8 (21.1) 52 (15.6)
    M. fortuitum complex 28 (14.2) 1 (1.8) 1 (3.6) 1 (7.1) 1 (2.6) 32 (9.6)
    M. chelonae 17 (8.6) 2 (3.5) 0 (0) 1 (7.1) 4 (10.5) 24 (7.2)
  Slow-growing species
    M. avium/intracellulare complex 70 (35.5) 45 (78.9) 23 (82.1) 9 (64.3) 20 (52.6) 167 (50)
    M. marinum 20 (10.2) 0 (0) 0 (0) 0 (0) 1 (2.6) 21 (6.3)
    M. goodii 5 (2.5) 0 (0) 1 (3.6) 0 (0) 0 (0) 6 (1.8)
    M. aubagnense 1 (0.5) 1 (1.8) 0 (0) 0 (0) 1 (2.6) 3 (0.9)
    M. xenopi 1 (0.5) 0 (0) 1 (3.6) 0 (0) 1 (2.6) 3 (0.9)
    M. alvei 2 (1) 0 (0) 0 (0) 0 (0) 0 (0) 2 (0.6)
    M. neoaurum 0 (0) 2 (3.5) 0 (0) 0 (0) 0 (0) 2 (0.6)
Other species‡ 13 (6.6) 4 (7) 1 (3.6) 2 (14.3) 2 (5.3) 22 (6.6)

*Values are no. (%) patients except as indicated. Total excludes 13 M. gordonae isolates: 6 skin/soft tissue, 1 disseminated, 1 lymph node, 5 other.
†Skin/soft tissue: wound, abscess, tissue, or exit catheter; disseminated: blood, bone marrow, cerebrospinal fluid, pericardial fluid, or peritoneal fluid; lymph node: lymph node or neck abscess; joint: synovial or joint fluid; other: urine, eye, sinus, or nasopharyngeal.
‡Other species were 8 unspeciated and 1 each of M. asiaticum, M. branderi, M. brisbanense, M. heckeshornense, M. immunogenum, M. interjectum, M. kansasii, M. lentiflavum, M. llaterense, M. mucogenicum/phocaicum, M. obuense, M. simiae, M. thermoresistible, and M. vaccae.

Main Article

Page created: September 18, 2017
Page updated: September 18, 2017
Page reviewed: September 18, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external